In vitro, promising data shows CAR T’s effect on ROR1 and an ongoing trial evaluating anti-ROR1 CART against ROR1 malignancy, including CLL (NCT02706392). The gene discussed is ROR1; the disease is B-cell chronic lymphocytic leukemia.